Oral immunotherapy for cow's milk allergy

Area of Science:

• Pediatric Allergy and Immunology
• Clinical Nutrition
• Immunotherapy

Background:

• Cow's milk allergy (CMA) is prevalent in children, posing risks of severe reactions.
• Current management relies solely on strict avoidance, which is challenging due to hidden milk.
• No pharmacological treatments exist, making desensitization a key research area.

Purpose of the Study:

• To evaluate the efficacy and safety of oral desensitization for pediatric cow's milk allergy.
• To explore immunotherapy as a viable alternative to strict avoidance diets.
• To assess the potential for broader application in other food allergies.

Main Methods:

• Review of recent clinical trials on oral desensitization protocols for cow's milk allergy.
• Analysis of reported outcomes, including tolerance achievement and side effect profiles.
• Assessment of treatment discontinuation rates and reasons.

Main Results:

• Multiple trials demonstrate favorable outcomes with high rates of full tolerance achieved.
• Mild side effects were common but manageable by adjusting desensitization pace.
• Severe side effects necessitating discontinuation occurred in less than 20% of participants.

Conclusions:

• Oral immunotherapy (desensitization) is a promising therapeutic strategy for pediatric CMA.
• The approach shows potential for successful application in managing other food allergies like egg and peanut.
• This immunotherapy offers a new avenue for managing food allergies beyond avoidance.